Analyses / BAC
Large-cap money center bank near the lower part of its 52-week range, with low multiples and thin provider coverage for key ratios.
A free account reveals BAC's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.
The Thesis
▲ Bull Case
Trades at 10.5x trailing P/E and 1.3x book value with a 3.2% dividend yield and 31% payout ratio. Price sits about 15% above its 52-week low of 46.12. Net margin of 29% and operating margin of 32.6% show strong profitability. If revenue growth stabilizes and earnings estimates hold, the valuation gap versus the 52-week high of 65.23 could narrow. Analyst price target raises appear in recent headlines.
▼ Bear Case
Revenue growth is only 0.6% against a 5-year average of 4.7%, and EPS growth is 5.6% versus 14.3% over five years. Shares fell 1.07% on the day and trade below the prior close of 49.44. Insider activity shows 257 sell transactions against 176 buys. Beta of 1.22 implies above-market sensitivity in a risk-off move. Several key bank ratios such as debt to equity and ROE are unavailable in the payload.
Valuation
FAIRLY VALUED — score 62/100
Low trailing and forward P/E with a solid dividend, offset by weak revenue growth and missing bank-specific ratios.
Technical Levels
Support · $48.74 (Current session low) · $46.12 (52-week low)
Resistance · $49.44 (Prior close) · $49.49 (Current session high)
RSI: Unavailable in payload
Financial Health
Score 60/100. Profitability and dividend coverage look solid in the payload. Standard leverage and liquidity ratios are missing, so balance sheet strength cannot be fully assessed here.
Catalysts
| Next earnings report | Date not provided in payload | high |
| Analyst price target actions | Ongoing, per recent headlines | medium |
| Revenue growth trend versus 5-year average | Next quarterly reports | medium |
Risk Flags
See BAC's full trade plan — free
Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.
Unlock BAC free →Recent News
- ETFs Are Buying Bank of America (BAC) on TuesdayYahoo
- Disney earnings beat estimates as Bank of America raises price target to $135Yahoo
- S&P 500 Most Active Stocks on Nov. 18: AES Leads Volume, Freeport-McMoRan Drops 6.45%ChartMill
- Home Depot sales momentum strengthens as Bank of America sees scope for share gainsYahoo
- Amazon to accelerate logistics expansion in 2027, says Bank of AmericaYahoo
You've read your 2 free analyses
Create a free account for unlimited analyses — every name on the page, plus live tools on 5,000+ tickers. No card required.
Read the full BAC analysis — free →Free to read · 2 analyses every 30 days without an account
More Analyses
BAC FAQ
Is BAC a buy right now?
Bank of America Corporation's current read is a Value with recovery watch setup with 52 confidence over a 1-3 months horizon. Valuation: FAIRLY VALUED. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.
Is BAC overvalued?
FAIRLY VALUED (valuation score 62/100). Low trailing and forward P/E with a solid dividend, offset by weak revenue growth and missing bank-specific ratios.
What are the risks of buying BAC?
Revenue growth is only 0.6% against a 5-year average of 4.7%, and EPS growth is 5.6% versus 14.3% over five years. Shares fell 1.07% on the day and trade below the prior close of 49.44. Insider activity shows 257 sell transactions against 176 buys. Beta of 1.22 implies above-market sensitivity in a risk-off move. Several key bank ratios such as debt to equity and ROE are unavailable in the payload.